1. Home
  2. MGIH vs INAB Comparison

MGIH vs INAB Comparison

Compare MGIH & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Millennium Group International Holdings Limited

MGIH

Millennium Group International Holdings Limited

HOLD

Current Price

$1.44

Market Cap

15.9M

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.45

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGIH
INAB
Founded
1978
2016
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.9M
15.6M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
MGIH
INAB
Price
$1.44
$1.45
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
8.7K
60.3K
Earning Date
10-28-2025
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.12
52 Week High
$4.84
$4.20

Technical Indicators

Market Signals
Indicator
MGIH
INAB
Relative Strength Index (RSI) 45.99 41.34
Support Level $1.39 $1.35
Resistance Level $1.58 $1.69
Average True Range (ATR) 0.09 0.08
MACD -0.02 -0.01
Stochastic Oscillator 5.26 13.79

Price Performance

Historical Comparison
MGIH
INAB

About MGIH Millennium Group International Holdings Limited

Millennium Group International Holdings Ltd supplies paper-based packaging solutions, including inner packaging boxes produced with offset or flexo printing and outer corrugated boxes used for transportation, storage, pallets, and point-of-purchase displays. The company manufactures corrugated products of different sizes, shapes, thicknesses, and strengths according to customer specifications. It also operates a supply chain management business in Vietnam to service international clients who source their packaging needs from Vietnam and other ASEAN countries. The corrugated paper is durable, versatile, economical, and lightweight.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

Share on Social Networks: